Where are the phase IIb results for Bimatoprost?

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • cocacola
    Senior Member
    • Feb 2013
    • 222

    Also would be great to have minutes of that r&d presentation as it doesnt tell the whole story.

    Comment

    • champpy
      Senior Member
      • Apr 2015
      • 336

      I too would give it a try, even if the effects were no better than minox.

      I do think their "enhanced" version of Bim will included Setipiprant. Bad thing about that is it will be a loooong time before that is ready, and its not even proven that Set will be of benefit. So for all we know, after the next Phase 2 we will still be in the same position as we are today, with mediocre results and them back to the drawing board.

      Its a damn shame though that this wont be produced because it would sell as an alternative to Minox. My guess is that right now its just to costly to produce on a large scale basis.

      As for sides, could the sides be any worse than what we get from Minox, fin or dut? I find it hard to believe that they would be.

      Since we now see that 1% bim does work to some degree, is it possible that we could get this from another supplier eventually or from the black market. We have the concentration, I think we just need a good vehicle now so that we know it actually penetrates the scalp

      2015 has been a bust. Im going to start a new thread here soon, but I keep thinking that 2017 is going to be the year we finally get a new product as 2016 will still be all about testing these new products out

      Comment

      • Occulus
        Senior Member
        • Dec 2013
        • 109

        Originally posted by champpy
        I too would give it a try, even if the effects were no better than minox.
        They won't release a bim-based product unless it is significantly better than minoxodil. Something that is only 10% better isn't going to cut it for financial reasons. Rogaine is pretty cheap now (it was initially $60 for three cans, now it can be found for half that price), as it's been on the market for so long. As a new product, bimotoprost won't be cheap for years, and will have to be priced at a premium to Rogaine. In order to justify the premium and outcompete Rogaine, it will have to be demonstrably better than Rogaine.

        I hope some people start experimenting with a 1% or even 3% solution, as that's about the only way we'll know for at least a couple years.

        Comment

        • unbalding
          Senior Member
          • Sep 2014
          • 140

          Is that pdf the only information they gave? There isn't in enough information there to make a definitive judgement. All we can tell is that the percentage of test subjects with a response of greater than 1 on their 3 point scale was about the same as minoxidil. How many in each group had a response of 2 or even 3? If that picture was the top responder then this is pretty much useless considering how long it will be before it gets to market. By that time we will hopefully have SM and Replicel which are both more promising than bim.

          Comment

          • rdawg
            Senior Member
            • Jun 2012
            • 996

            This is an interesting one, seems clearly equal to Minox at lower dosage and about 10-20% better at higher dosage.

            If they can improve the delivery like they are saying they may be on to something.

            you guys can scoff and cry saying this isn't good enough, but this clearly shows positive efficacy, could last longer than Minox and already improves over minox at a higher percentage.

            At the very least this looks like a viable treatment in 2-3 years at most, remember they are going straight to 2B with a higher dose/different delivery, once they find the perfect delivery, as they have already proven efficacy, they can push it forward straight into phase III.

            there's nothing here that says failure, just have to wait a slightly longer amount of time(2-3 years instead of 1 year going straight to Phase III).

            Add on top of this we will be getting a Propecia/DUT replacement soon as well in SETI as they seem to be onto something there and that goes straight to phase II.

            Comment

            • rdawg
              Senior Member
              • Jun 2012
              • 996

              Originally posted by champpy
              I too would give it a try, even if the effects were no better than minox.

              I do think their "enhanced" version of Bim will included Setipiprant. Bad thing about that is it will be a loooong time before that is ready, and its not even proven that Set will be of benefit. So for all we know, after the next Phase 2 we will still be in the same position as we are today, with mediocre results and them back to the drawing board.

              Its a damn shame though that this wont be produced because it would sell as an alternative to Minox. My guess is that right now its just to costly to produce on a large scale basis.

              As for sides, could the sides be any worse than what we get from Minox, fin or dut? I find it hard to believe that they would be.

              Since we now see that 1% bim does work to some degree, is it possible that we could get this from another supplier eventually or from the black market. We ha vethe concentration, I think we just need a good vehicle now so that we know it actually penetrates the scalp
              I would think that would be extremely expensive, I recall people saying 0.1% was very costly, you'd have to be rich to afford 3%.(similar problem with CB being tested at a high dose but would be more than a HT to test on the grey market).

              in regard to your first point, it seems clear they know the dose they need to aim for now and just need to perfect it(although it's annoying that this cant be tested out in a phase III, just adds an extra year) so there's nothing negative to be taken from here. Seti is promising as it's already been tested in a Phase I by over 1000 respondents, and can likely be fast tracked within 3-4 years.

              I think the key to take from this is, BIM is coming out(and likely SETI as well), it's just finding the perfect dose. We're not in a 5 year range here anymore, more of a 2-3 year timeframe until we get at the very least an alternative to minox(and for many, this may work for people where minox didnt!).

              Comment

              • rdawg
                Senior Member
                • Jun 2012
                • 996

                Only thing I'm confused on is this whole Subject self assesment vs. panel review vs. investigator global assesment.

                what does that all mean exactly and how are they so different in their findings, as the latter two showed a 10-15% improvement over minox 5%

                Comment

                • champpy
                  Senior Member
                  • Apr 2015
                  • 336

                  I wish they would have actually done a hair count difference, to see if any new hair actually grew. For all we know it might have just strenghtened his existing hair and not grown anything new

                  Comment

                  • It's2014ComeOnAlready
                    Senior Member
                    • Sep 2014
                    • 584

                    Originally posted by rdawg
                    I would think that would be extremely expensive, I recall people saying 0.1% was very costly, you'd have to be rich to afford 3%.(similar problem with CB being tested at a high dose but would be more than a HT to test on the grey market).

                    in regard to your first point, it seems clear they know the dose they need to aim for now and just need to perfect it(although it's annoying that this cant be tested out in a phase III, just adds an extra year) so there's nothing negative to be taken from here. Seti is promising as it's already been tested in a Phase I by over 1000 respondents, and can likely be fast tracked within 3-4 years.

                    I think the key to take from this is, BIM is coming out(and likely SETI as well), it's just finding the perfect dose. We're not in a 5 year range here anymore, more of a 2-3 year timeframe until we get at the very least an alternative to minox(and for many, this may work for people where minox didnt!).
                    These are all positive takeaways, and they are logical. Not over-speculation, not overly negative or positive. The truth is that we have a few treatments that are close, and hopefully the 21st Century Cures Act will help speed things up with all three. It's very likely it will, and Samumed at least has biomarker and surrogate endpoint data to support an alternative phase 3. Not to forget that Seti has conducted 8 clinical trials, with excellent safety data. Bim has also showed effectiveness AND safety in their trials.

                    imo it's a game of t-ball, fellas. It's sitting right there to be knocked out of the park. Great things for all of us will be here very soon. Hold on.

                    As far as the bill goes, the senator authoring the bill (Lamar Alexander) based on the one passed in congress, has previously published a few papers advocating for the FDA to speed up their trials and use biomarker and surrogate endpoint data. AND the new FDA chief, Dr. Robert Califf, installed by Obama has also written papers calling for the same.

                    Comment

                    • Hemo
                      Senior Member
                      • Apr 2015
                      • 138

                      Eh, sounds to me like they're just putting it off until it can be tested/released alongside seti.

                      Comment

                      • cocacola
                        Senior Member
                        • Feb 2013
                        • 222

                        Can someone illuminate me on phase 2b trial vs going into phase 3 and what could be the possible timelines to release in downside base and positive scenarios?

                        Comment

                        • rdawg
                          Senior Member
                          • Jun 2012
                          • 996

                          Originally posted by cocacola
                          Can someone illuminate me on phase 2b trial vs going into phase 3 and what could be the possible timelines to release in downside base and positive scenarios?
                          basically bumps it back a year, my guess is there are regulations where they cant just test a higher dose at phase III, they have to do a phase IIb all over again.

                          They've shown it works to an extent at 1% but 3% has shown to be even better.

                          timeline wise, if it went straight to phase III, we're talking Q1 2017 release, but since it's going back to phase IIb(and i find it near impossible they dont find what they are looking for this time) most likely a Q1-2 2018 release at best, Q4 2018-Q1 2019 at worst.

                          The positive news is they believe it works, I doubt a company would truly invest this much money and time into something they dont plan on pushing forward, they really want to maximize it's efficacy and possibly pair it with SETI. It's effective, it just needs to be perfected. Be happy we're talking 2-3 years at most!

                          Comment

                          • Hemo
                            Senior Member
                            • Apr 2015
                            • 138

                            Originally posted by cocacola
                            Can someone illuminate me on phase 2b trial vs going into phase 3 and what could be the possible timelines to release in downside base and positive scenarios?
                            I think it's a combination of dosage and delivery. It sounds like the "enhanced" version is more than just a higher dosage, so they likely have to test it before moving onto phase 3. I guess it's a good sign they're confident enough that the new formula will work/be better to put it through a trial.

                            Comment

                            • lacazette
                              Senior Member
                              • May 2015
                              • 394

                              Regarding Bim, there's also the japanese equivalent developed by R-Tech Ueno

                              RK-023 (Nobiprostlan), an eyeleash drug tested for alopecia

                              In their pipeline from June 2015, RK-023 was about to enter phase2b and was 'open to license' ("RTU is aiming to make profit early by license or joint development")

                              http://rtechueno.com/en/company/busi...ness.html#rd09 (scroll to the middle for the pipeline)

                              so maybe it's another company now that continue the trials, or maybe they are in a joint development

                              Comment

                              • Paul73
                                Member
                                • May 2014
                                • 64

                                Hello guys,

                                Please, whatīs your opinion on latanoprost? Do you think it could give similar results to Bim? I know we donīt have enough info about Bim., but many local pharmacies here in Brazil are already selling latanoprost. So at least the safety of the formula seems to be proven.

                                Should i give it a try? Let me know your thoughts. Thanks!

                                Comment

                                Working...